HPR138 A Non-Representative Sample: Racial and Ethnic Diversity in Clinical Trials of FDA-Approved Drugs
0
Authors
Michael Andrawes
Michael Andrawes•Kassandra SCHAIBLE•Sarah Ronnebaum
Published
June 1, 2024
Abstract
Given recent emphasis on clinical trial diversity by both the FDA and ICER, we sought to evaluate racial and ethnic representation in pivotal trials of FDA-approved drugs.
